COVID-19: Outcomes of patients with confirmed COVID-19 re-admitted to hospital.
作者信息
Rokadiya S, Gil E, Stubbs C, Bell D, Herbert R
机构信息
Department of Microbiology and Infection, North Middlesex University Hospital, Sterling Way, London, N18 1QX, UK.
Department of Microbiology and Infection, North Middlesex University Hospital, Sterling Way, London, N18 1QX, UK.
出版信息
J Infect. 2020 Sep;81(3):e18-e19. doi: 10.1016/j.jinf.2020.07.007. Epub 2020 Jul 8.
Abstract
摘要
相似文献
1
COVID-19: Outcomes of patients with confirmed COVID-19 re-admitted to hospital.新冠病毒病（COVID-19）：确诊感染新冠病毒病后再次入院患者的治疗结果
J Infect. 2020 Sep;81(3):e18-e19. doi: 10.1016/j.jinf.2020.07.007. Epub 2020 Jul 8.
2
COVID-19 Australia: Epidemiology Report 28: Fortnightly reporting period ending 25 October 2020.澳大利亚2019冠状病毒病：流行病学报告第28期：截至2020年10月25日的两周报告期。
Commun Dis Intell (2018). 2020 Oct 4;44. doi: 10.33321/cdi.2020.44.84.
3
Rhabdomyolysis as Potential Late Complication Associated with COVID-19.横纹肌溶解症作为与2019冠状病毒病相关的潜在晚期并发症
Emerg Infect Dis. 2020 Oct;26(10):2535. doi: 10.3201/eid2610.202225. Epub 2020 Jul 2.
4
Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2.SARS-CoV-2 引起的 COVID-19 肺炎患者的死亡预测因子。
Eur Respir J. 2020 Sep 24;56(3). doi: 10.1183/13993003.02961-2020. Print 2020 Sep.
5
Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2.SARS-CoV-2 引起的 COVID-19 肺炎患者的死亡预测因素。
Eur Respir J. 2020 Sep 24;56(3). doi: 10.1183/13993003.02439-2020. Print 2020 Sep.
6
Temperature-dependent surface stability of SARS-CoV-2.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的温度依赖性表面稳定性
J Infect. 2020 Sep;81(3):452-482. doi: 10.1016/j.jinf.2020.05.074. Epub 2020 Jun 3.
7
Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19.一名新冠肺炎患者肺部的组织病理学变化及严重急性呼吸综合征冠状病毒2免疫染色
Ann Intern Med. 2020 Aug 18;173(4):323-324. doi: 10.7326/L20-0894.
8
Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19.新型冠状病毒肺炎患者肺部的组织病理学变化及严重急性呼吸综合征冠状病毒2免疫染色
Ann Intern Med. 2020 Aug 18;173(4):324. doi: 10.7326/L20-0895.
9
Flattening the curve of new publications on COVID-19.平缓新冠疫情相关新出版物的增长曲线。
J Epidemiol Community Health. 2020 Sep;74(9):766-767. doi: 10.1136/jech-2020-214617. Epub 2020 Jul 6.
10
Faecal shedding of SARS-CoV-2: considerations for hospital settings.新型冠状病毒肺炎（SARS-CoV-2）的粪便排毒：医院环境中的注意事项。
J Hosp Infect. 2020 Aug;105(4):782-783. doi: 10.1016/j.jhin.2020.05.019. Epub 2020 May 20.
引用本文的文献
1
COVID-19 Readmission Is Highest Among Refugees in Denmark.丹麦难民中新冠病毒病再入院率最高。
Int J Environ Res Public Health. 2025 Mar 3;22(3):367. doi: 10.3390/ijerph22030367.
2
Remdesivir Effectiveness in Reducing the Risk of 30-Day Readmission in Vulnerable Patients Hospitalized for COVID-19: A Retrospective US Cohort Study Using Propensity Scores.瑞德西韦对降低COVID-19住院脆弱患者30天再入院风险的有效性：一项使用倾向评分的美国回顾性队列研究。
Clin Infect Dis. 2024 Dec 13;79(Suppl 4):S167-S177. doi: 10.1093/cid/ciae511.
3
Cost-effectiveness of therapeutics for COVID-19 patients: a rapid review and economic analysis.COVID-19 患者治疗的成本效益：快速综述和经济分析。
Health Technol Assess. 2023 Aug;27(14):1-92. doi: 10.3310/NAFW3527.
4
Characteristics of re-admitted adult patients infected with severe acute respiratory syndrome Coronavirus 2 After initial hospitalization at King Salman Armed Forces Hospital, Tabuk, Saudi Arabia.沙特阿拉伯塔布克的国王萨勒曼武装部队医院初次住院后再次入院的成人严重急性呼吸综合征冠状病毒 2 感染患者的特征。
Saudi Med J. 2023 Jul;44(7):647-654. doi: 10.15537/smj.2023.44.7.20220713.
5
Six-month Morbidity and Mortality in Patients after Recovery from COVID-19.新冠病毒病康复患者的六个月发病率和死亡率
Indian J Crit Care Med. 2022 Nov;26(11):1179-1183. doi: 10.5005/jp-journals-10071-24347.
6
Hospital Readmissions Among Veterans Within 90 Days of Discharge Following Initial Hospitalization for COVID-19.COVID-19 初次住院出院后 90 天内退伍军人的住院再入院率。
Prev Chronic Dis. 2022 Dec 1;19:E80. doi: 10.5888/pcd19.220200.
7
Hospital readmissions and emergency department re-presentation of COVID-19 patients: a systematic review.新冠病毒肺炎患者的医院再入院及急诊科再次就诊情况：一项系统综述
Rev Panam Salud Publica. 2022 Oct 10;46:e142. doi: 10.26633/RPSP.2022.142. eCollection 2022.
8
Comparison of Hospital Readmission and Mortality between COVID-19 and Pneumonia Patients.新冠病毒肺炎患者与肺炎患者的再入院率及死亡率比较
J Clin Med. 2022 Jul 20;11(14):4199. doi: 10.3390/jcm11144199.
9
COVID-19 pandemic in Southern Brazil: Hospitalizations, intensive care unit admissions, lethality rates, and length of stay between March 2020 and April 2022.2020 年 3 月至 2022 年 4 月期间巴西南部的 COVID-19 大流行：住院、重症监护病房入院、死亡率和住院时间。
J Med Virol. 2022 Oct;94(10):4839-4849. doi: 10.1002/jmv.27942. Epub 2022 Jun 23.
10
Longer length of stay, days between discharge/first readmission, and pulmonary involvement ≥50% increase prevalence of admissions in ICU in unplanned readmissions after COVID-19 hospitalizations.新冠肺炎住院后非计划性再入院时，住院时间延长、出院/首次再入院间隔天数增加以及肺部受累≥50%，会增加 ICU 收治率。
J Med Virol. 2022 Aug;94(8):3750-3756. doi: 10.1002/jmv.27792. Epub 2022 May 4.
本文引用的文献
1
Black, Asian and Minority Ethnic groups in England are at increased risk of death from COVID-19: indirect standardisation of NHS mortality data.英格兰的黑人、亚裔和少数族裔群体死于新冠病毒的风险更高：英国国家医疗服务体系（NHS）死亡率数据的间接标准化
Wellcome Open Res. 2020 Jun 24;5:88. doi: 10.12688/wellcomeopenres.15922.2. eCollection 2020.
2
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区，5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
3
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.中国 COVID-19 患者 1590 例的合并症及其影响：一项全国性分析。
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00547-2020. Print 2020 May.
4
Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation.严重急性呼吸综合征冠状病毒 2 再激活的临床特征。
J Infect. 2020 May;80(5):e14-e17. doi: 10.1016/j.jinf.2020.03.001. Epub 2020 Mar 20.
5
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
Zotero 插件